Powers Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Powers Advisory Group's LLY Position: Q2 2026 in Review
Powers Advisory Group reduced its Eli Lilly (LLY) stake by 11% in Q2 2026, selling an estimated $257K and leaving 1,964 shares worth $2.36M. The position accounts for 0.74% of the portfolio, ranked #25.
Powers Advisory Group first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.47M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Powers Advisory Group held 1,964 shares of Eli Lilly worth $2.36M as of Q2 2026.
- Powers Advisory Group sold 252 Eli Lilly shares in Q2 2026, an estimated $257K.
- Eli Lilly made up 0.74% of Powers Advisory Group's portfolio in Q2 2026, its #25 holding.
- Powers Advisory Group first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- Powers Advisory Group's Eli Lilly position peaked at $2.47M in Q4 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Powers Advisory Group's 13F filing for Q2 2026, filed 31 Jul 2026.